fibromyalgia |
Disease ID | 73 |
---|---|
Disease | fibromyalgia |
Definition | A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95) |
Synonym | diffuse myofascial pain syndrome fibromyalgia (disorder) fibromyalgia (finding) fibromyalgia (fm) fibromyalgia (fms) fibromyalgia -retired- fibromyalgia [ambiguous] fibromyalgia [disease/finding] fibromyalgia fibromyositis syndrome fibromyalgia syndrome fibromyalgia, nos fibromyalgia-fibromyositis syndrome fibromyalgia-fibromyositis syndromes fibromyalgias fibromyositis fibromyositis (disorder) fibromyositis fibromyalgia syndrome fibromyositis nos fibromyositis nos (disorder) fibromyositis, nos fibromyositis-fibromyalgia syndrome fibromyositis-fibromyalgia syndromes fibrositides fibrositis fibrositis (disorder) fibrositis nos fibrositis unspecified fibrositis unspecified (disorder) fibrositis, nos fms mpd syndrome mpds (myofascial pain dysfunction syndrome) mpds - myofacial pain dysfunction syndrome muscular rheumatism muscular rheumatism (disorder) myofacial pain dysfunction syndrome myofascial pain dysfunction syndrome myofascial pain syndrome myofascial pain syndrome, diffuse pain syndrome myofascial rheumatism, muscular rheumatism, tension syndrome fibromyalgia syndrome, fibromyalgia-fibromyositis syndrome, fibromyositis-fibromyalgia syndromes, fibromyalgia-fibromyositis syndromes, fibromyositis-fibromyalgia |
OMIM | |
DOID | |
ICD10 | |
UMLS | C0016053 |
MeSH | |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:85) C0011570 | depression | 25 C0016053 | myofascial pain syndrome | 14 C0003873 | rheumatoid arthritis | 9 C0003467 | anxiety | 6 C0003864 | arthritis | 5 C0679466 | cognitive deficits | 3 C0041696 | major depression | 3 C0022104 | irritable bowel syndrome | 3 C0002020 | alexithymia | 3 C0037317 | sleep disturbance | 3 C0028754 | obesity | 3 C0851578 | sleep disorders | 3 C0038013 | ankylosing spondylitis | 3 C0149931 | migraine | 3 C0010068 | coronary heart disease | 2 C0004936 | mental disorders | 2 C0006142 | breast cancer | 2 C0018799 | heart disease | 2 C0035435 | rheumatic disease | 2 C0039494 | temporomandibular disorder | 2 C0035258 | restless legs | 2 C0035258 | restless legs syndrome (rls) | 2 C0035435 | rheumatic diseases | 2 C0039494 | temporomandibular disorders | 2 C0038436 | posttraumatic stress disorder | 2 C1527336 | sjogren's syndrome | 2 C0035258 | restless legs syndrome | 2 C0019158 | hepatitis | 2 C0022104 | irritable bowel | 2 C0029408 | osteoarthritis | 2 C0149931 | migraine headache | 1 C0006325 | bruxism | 1 C0037317 | sleep disturbances | 1 C0009241 | cognitive disorders | 1 C0149931 | migraine headaches | 1 C0003864 | inflammatory arthritis | 1 C0019196 | hepatitis c infection | 1 C0949690 | spondyloarthritis | 1 C0039263 | takayasu's arteritis | 1 C0042485 | venous insufficiency | 1 C0011847 | diabetes | 1 C0042870 | vitamin d defic | 1 C0029455 | osteopoikilosis | 1 C0041696 | major depressive disorder | 1 C0020502 | hyperparathyroidism | 1 C0042870 | vitamin d deficiency | 1 C0014175 | endometriosis | 1 C0314719 | dry eye | 1 C1510471 | hypovitaminosis | 1 C0015464 | facial nerve palsy | 1 C0003872 | psoriatic arthritis | 1 C0007222 | cardiovascular disease | 1 C0221757 | alpha-1-antitrypsin deficiency | 1 C0442874 | neuropathy | 1 C0015674 | chronic fatigue syndrome | 1 C0031069 | familial mediterranean fever | 1 C0003469 | anxiety disorders | 1 C0221002 | primary hyperparathyroidism | 1 C0032002 | pituitary disorders | 1 C0030305 | pancreatitis | 1 C0007570 | celiac disease | 1 C0026267 | mitral valve prolapse | 1 C0004943 | behcet's disease | 1 C0242490 | enthesopathy | 1 C0019196 | hepatitis c | 1 C0021053 | immune disease | 1 C0035579 | hypovitaminosis d | 1 C0013421 | dystonia | 1 C0700594 | radiculopathy | 1 C0221757 | aat deficiency | 1 C0016053 | fibromyalgia | 1 C0042769 | virus infection | 1 C0020676 | hypothyroidism | 1 C0038012 | spondylitis | 1 C0152078 | pelvic pain syndrome | 1 C0002395 | alzheimer disease | 1 C0002895 | sickle cell disease | 1 C0018916 | angioma | 1 C0001339 | acute pancreatitis | 1 C0028754 | adiposity | 1 C0221757 | alpha-1-antitrypsin def | 1 C0019163 | hepatitis b | 1 C0003469 | anxiety disorder | 1 C0042373 | vascular disease | 1 C0035435 | rheumatism | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:11) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:121) 10555 | AGPAT2 | 2.059 | DISEASES 238 | ALK | 2.142 | DISEASES 257 | ALX3 | 1.524 | DISEASES 11273 | ATXN2L | 1.974 | DISEASES 554 | AVPR2 | 1.394 | DISEASES 627 | BDNF | 2.628 | DISEASES 627 | BDNF | 2.617 | DISEASES 388552 | BLOC1S3 | 2.018 | DISEASES 26580 | BSCL2 | 1.855 | DISEASES 149466 | C1orf210 | 2.132 | DISEASES 778 | CACNA1F | 1.51 | DISEASES 796 | CALCA | 1.291 | DISEASES 820 | CAMP | 2.776 | DISEASES 820 | CAMP | 1.111 | DISEASES 388372 | CCL4L1 | 1.502 | DISEASES 388372 | CCL4L1 | 1.234 | DISEASES 914 | CD2 | 2.667 | DISEASES 959 | CD40LG | 2.765 | DISEASES 921 | CD5 | 2.424 | DISEASES 1041 | CDSN | 3.418 | DISEASES 63924 | CIDEC | 2.458 | DISEASES 1312 | COMT | 3.818 | DISEASES 56259 | CTNNBL1 | 1.233 | DISEASES 2833 | CXCR3 | 1.039 | DISEASES 50626 | CYHR1 | 2.267 | DISEASES 1544 | CYP1A2 | 1.131 | DISEASES 1565 | CYP2D6 | 1.903 | DISEASES 9879 | DDX46 | 2.417 | DISEASES 1805 | DPT | 1.575 | DISEASES 1806 | DPYD | 1.02 | DISEASES 23741 | EID1 | 1.221 | DISEASES 954 | ENTPD2 | 1.092 | DISEASES 51013 | EXOSC1 | 1.292 | DISEASES 26190 | FBXW2 | 1.847 | DISEASES 11153 | FICD | 1.402 | DISEASES 2332 | FMR1 | 2.128 | DISEASES 221937 | FOXK1 | 1.858 | DISEASES 2556 | GABRA3 | 1.582 | DISEASES 2624 | GATA2 | 2.287 | DISEASES 2633 | GBP1 | 1.042 | DISEASES 51738 | GHRL | 1.25 | DISEASES 2879 | GPX4 | 3.022 | DISEASES 51696 | HECA | 1.072 | DISEASES 3250 | HPR | 1.038 | DISEASES 3356 | HTR2A | 2.909 | DISEASES 3359 | HTR3A | 4.159 | DISEASES 3363 | HTR7 | 3.067 | DISEASES 3620 | IDO1 | 1.728 | DISEASES 3456 | IFNB1 | 2.451 | DISEASES 3486 | IGFBP3 | 1.691 | DISEASES 8518 | IKBKAP | 1.286 | DISEASES 3586 | IL10 | 2.407 | DISEASES 3563 | IL3RA | 1.864 | DISEASES 50618 | ITSN2 | 2.972 | DISEASES 3713 | IVL | 1.451 | DISEASES 102723508 | KANTR | 2.93 | DISEASES 102723508 | KANTR | 2.087 | DISEASES 3776 | KCNK2 | 2.488 | DISEASES 8564 | KMO | 1.044 | DISEASES 348801 | LNP1 | 1.661 | DISEASES 4094 | MAF | 1.849 | DISEASES 4128 | MAOA | 1.648 | DISEASES 5609 | MAP2K7 | 1.288 | DISEASES 4191 | MDH2 | 1.441 | DISEASES 79104 | MEG8 | 2.151 | DISEASES 8972 | MGAM | 2.044 | DISEASES 4599 | MX1 | 1.188 | DISEASES 23040 | MYT1L | 1.67 | DISEASES 79903 | NAA60 | 2.439 | DISEASES 89796 | NAV1 | 1.448 | DISEASES 89795 | NAV3 | 1.57 | DISEASES 4686 | NCBP1 | 1.322 | DISEASES 4803 | NGF | 2.165 | DISEASES 4803 | NGF | 1.51 | DISEASES 114548 | NLRP3 | 1.186 | DISEASES 654364 | NME1-NME2 | 1.342 | DISEASES 594857 | NPS | 3.673 | DISEASES 594857 | NPS | 1.605 | DISEASES 4306 | NR3C2 | 1.141 | DISEASES 9369 | NRXN3 | 1.309 | DISEASES 4914 | NTRK1 | 1.217 | DISEASES 4988 | OPRM1 | 2.537 | DISEASES 5005 | ORM2 | 1.596 | DISEASES 5025 | P2RX4 | 1.847 | DISEASES 10606 | PAICS | 1.426 | DISEASES 55010 | PARPBP | 3.225 | DISEASES 5223 | PGAM1 | 1.1 | DISEASES 5406 | PNLIP | 2.544 | DISEASES 5478 | PPIA | 1.114 | DISEASES 5535 | PPP3R2 | 2.48 | DISEASES 5550 | PREP | 2.486 | DISEASES 5627 | PROS1 | 2.399 | DISEASES 5696 | PSMB8 | 2.718 | DISEASES 9051 | PSTPIP1 | 3.425 | DISEASES 284119 | PTRF | 1.868 | DISEASES 6014 | RIT2 | 1.065 | DISEASES 57142 | RTN4 | 1.617 | DISEASES 6336 | SCN10A | 1.314 | DISEASES 6335 | SCN9A | 2.702 | DISEASES 5265 | SERPINA1 | 4.526 | DISEASES 59307 | SIGIRR | 1.161 | DISEASES 6533 | SLC6A6 | 2.694 | DISEASES 23583 | SMUG1 | 1.925 | DISEASES 6633 | SNRPD2 | 1.529 | DISEASES 6635 | SNRPE | 2.592 | DISEASES 6635 | SNRPE | 1.899 | DISEASES 6693 | SPN | 1.913 | DISEASES 8676 | STX11 | 1.118 | DISEASES 6863 | TAC1 | 4.708 | DISEASES 6863 | TAC1 | 3.046 | DISEASES 54790 | TET2 | 1.319 | DISEASES 7072 | TIA1 | 4.339 | DISEASES 7124 | TNF | 3.058 | DISEASES 7133 | TNFRSF1B | 2.086 | DISEASES 1861 | TOR1A | 1.266 | DISEASES 51592 | TRIM33 | 1.046 | DISEASES 7442 | TRPV1 | 2.319 | DISEASES 162514 | TRPV3 | 1.241 | DISEASES 706 | TSPO | 1.501 | DISEASES 11169 | WDHD1 | 1.207 | DISEASES 10269 | ZMPSTE24 | 1.791 | DISEASES |
Locus | (Waiting for update.) |
Disease ID | 73 |
---|---|
Disease | fibromyalgia |
Manually Symptom | UMLS | Name(Total Manually Symptoms:53) C2678504 | osteoporosis C2598155 | pain C2364133 | infection C2364072 | depression C2364051 | fatigue C2096315 | headache C2020637 | chronic pain C1963237 | insomnia C1963185 | obesity C1963064 | anxiety C1839611 | n syndrome C1720505 | adult growth hormone deficiency C1718184 | pain symptoms C1335778 | retroperitoneal leiomyosarcoma C1269683 | major depressive disorder C0851578 | sleep disturbances C0851578 | sleep disorders C0813142 | circadian rhythm disorders C0741585 | body pain C0717360 | lyme disease C0700361 | distress C0700201 | sleep disturbance C0684239 | tenderness C0575064 | muscle tenderness C0559031 | functional gastrointestinal disorders C0553844 | keratoconjunctivitis sicca C0549622 | sexual dysfunction C0521991 | stress symptoms C0497552 | nervous system abnormalities C0427008 | stiffness C0426576 | gastrointestinal symptoms C0278140 | severe pain C0262405 | cerebral dysfunction C0235704 | adynamia C0235169 | excitability C0234244 | somatic pain C0231528 | muscular pain C0151825 | skeletal pain C0151293 | chronic headache C0149645 | cervical myelopathy C0086132 | depressive symptoms C0085616 | vasospasm C0039494 | temporomandibular disorders C0039494 | temporomandibular disorder C0035258 | restless legs syndrome (rls) C0034735 | raynaud's syndrome C0034735 | raynaud phenomenon C0025322 | early menopause C0022104 | irritable bowel syndrome C0013363 | dysautonomia C0007384 | cataplexy C0007286 | carpal tunnel syndrome C0004364 | autoimmune diseases |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:24) C0030193 | pain | 73 C0011570 | depression | 25 C0150055 | chronic pain | 16 C0015672 | fatigue | 11 C0086132 | depressive symptoms | 6 C0003467 | anxiety | 6 C1839611 | n syndrome | 3 C0028754 | obesity | 3 C0851578 | sleep disorders | 3 C0018681 | headache | 3 C0022104 | irritable bowel syndrome | 3 C0035258 | restless legs syndrome (rls) | 2 C0037317 | sleep disturbance | 2 C0039494 | temporomandibular disorders | 2 C0234233 | tenderness | 1 C0741585 | body pain | 1 C0427008 | stiffness | 1 C0004364 | autoimmune diseases | 1 C0231303 | distress | 1 C0917801 | insomnia | 1 C0024198 | lyme disease | 1 C0037317 | sleep disturbances | 1 C0041696 | major depressive disorder | 1 C0235169 | excitability | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:22) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1799971 | 24671502 | 4988 | OPRM1 | umls:C0016053 | BeFree | Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. | 0.005634266 | 2014 | OPRM1 | 6 | 154039662 | A | G |
rs1799983 | 16951945 | 4846 | NOS3 | umls:C0016053 | BeFree | No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. | 0.002995792 | 2007 | NOS3 | 7 | 150999023 | T | G |
rs3771863 | 25786041 | 6869 | TACR1 | umls:C0016053 | BeFree | The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients. | 0.002638474 | 2014 | TACR1;LOC105374811 | 2 | 75192588 | C | T |
rs386602118 | 21773883 | 627 | BDNF | umls:C0016053 | BeFree | A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein. | 0.002995792 | 2012 | NA | NA | NA | NA | NA |
rs386602276 | 21120487 | 3356 | HTR2A | umls:C0016053 | BeFree | This meta-analysis demonstrates that the 5-HT2A receptor 102T/C polymorphism confers susceptibility to fibromyalgia. | 0.003995683 | 2012 | NA | NA | NA | NA | NA |
rs386602276 | 11732859 | 3356 | HTR2A | umls:C0016053 | BeFree | Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. | 0.003995683 | 2001 | NA | NA | NA | NA | NA |
rs386602276 | 22124593 | 3356 | HTR2A | umls:C0016053 | BeFree | Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. | 0.003995683 | 2011 | NA | NA | NA | NA | NA |
rs386602276 | 10527809 | 3356 | HTR2A | umls:C0016053 | BeFree | The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. | 0.003995683 | 1999 | NA | NA | NA | NA | NA |
rs4680 | 23025981 | 1312 | COMT | umls:C0016053 | BeFree | Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. | 0.023451079 | 2012 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 24762091 | 1312 | COMT | umls:C0016053 | BeFree | Clinical symptoms in fibromyalgia are associated to catechol-O-methyltransferase (COMT) gene Val158Met polymorphism. | 0.023451079 | 2015 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 21120493 | 1312 | COMT | umls:C0016053 | BeFree | These results suggest that SNPs rs4680 and rs4818 of the COMT gene may be associated with fibromyalgia and pain sensitivity in FS Brazilian patients. | 0.023451079 | 2012 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 20074440 | 1312 | COMT | umls:C0016053 | BeFree | The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. | 0.023451079 | 2009 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 24503977 | 1312 | COMT | umls:C0016053 | BeFree | Has catechol-O-methyltransferase genotype (Val158Met) an influence on endocrine, sympathetic nervous and humoral immune systems in women with fibromyalgia syndrome? | 0.023451079 | 2014 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 18196244 | 3356 | HTR2A | umls:C0016053 | BeFree | The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. | 0.003995683 | 2008 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4680 | 24951880 | 1312 | COMT | umls:C0016053 | BeFree | Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis. | 0.023451079 | 2014 | COMT;MIR4761 | 22 | 19963748 | G | A |
rs4818 | 21120493 | 1312 | COMT | umls:C0016053 | BeFree | These results suggest that SNPs rs4680 and rs4818 of the COMT gene may be associated with fibromyalgia and pain sensitivity in FS Brazilian patients. | 0.023451079 | 2012 | COMT;MIR4761 | 22 | 19963684 | C | G,T |
rs6311 | 18196244 | 3356 | HTR2A | umls:C0016053 | BeFree | The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. | 0.003995683 | 2008 | HTR2A | 13 | 46897343 | C | T |
rs6313 | 18196244 | 3356 | HTR2A | umls:C0016053 | BeFree | The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. | 0.003995683 | 2008 | HTR2A | 13 | 46895805 | G | A |
rs6313 | 22124593 | 3356 | HTR2A | umls:C0016053 | BeFree | Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. | 0.003995683 | 2011 | HTR2A | 13 | 46895805 | G | A |
rs6313 | 11732859 | 3356 | HTR2A | umls:C0016053 | BeFree | Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. | 0.003995683 | 2001 | HTR2A | 13 | 46895805 | G | A |
rs6313 | 21120487 | 3356 | HTR2A | umls:C0016053 | BeFree | This meta-analysis demonstrates that the 5-HT2A receptor 102T/C polymorphism confers susceptibility to fibromyalgia. | 0.003995683 | 2012 | HTR2A | 13 | 46895805 | G | A |
rs6313 | 10527809 | 3356 | HTR2A | umls:C0016053 | BeFree | The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. | 0.003995683 | 1999 | HTR2A | 13 | 46895805 | G | A |
GWASdb Annotation(Total Genotypes:13) | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Pos | SNP_Id | RefGene | EnsemblGene | ENCODE_Factor | ENCODE_TFBS | Chromosome_interaction | GTEx_eQTL | SNP_TFBS_affinity_GWAS3D | SNP_miRNA_target_affinity_PolymiRTS | SNP_splicing_effect_Skippy | SNP_splicing_effect_MutPred_Splice | SNP_ns_protein_effect_dbNSFP | SNP_syn_effect_Silva | SNP_phosphorylation_effect_PhosSNP | PhastCons_score | PhyloP_score | GERP++_RS | Segway_state | Ancestral_allele | ESP_AF | ESP_AFR | ESP_AFR | ESP_EUR | TG_ASN | TG_AMR | TG_AFR | TG_EUR | Type | Consequence | bStatistic | EncH3K27Ac | EncH3K4Me1 | EncH3K4Me3 | EncNucleo | OMIM | Clinvar |
5 | 149440045 | rs12516676 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000515068,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | NA | NA | NA | NA | Asg1-DBD-primary,7.9738 | Asg1-DBD-primary,1.3568 | Asg1-DBD-primary,24.186 | Asg1-DBD-primary,66.5157 | Asg1-DBD-primary,4.0317 | NA | NA | NA | NA | NA | NA | 0.000 | -0.741 | -3.87 | R3 | C | NA | NA | NA | NA | NA | NA | NA | NA |
5 | 149443298 | rs216140 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | NA | NA | NA | NA | Gat1-primary,8.3728 | Gzf3-primary,10.1043 | Rdr1-DBD-primary,1.6969 | Tbf1-DBD-primary,7.3762 | Tec1-primary,5.0564 | NA | NA | NA | NA | NA | NA | 0.000 | -1.885 | -8.27 | R3 | T | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
5 | 149445595 | rs216145 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | TFP.MAX | NA | NA | NA | Aro80-primary,1.7456 | Ecm22-primary,2.4161 | Gal4-primary,1.6751 | Gal4-primary,1.3214 | Gsm1-FL-primary,1.5537 | NA | NA | NA | NA | NA | NA | 0.000 | -0.207 | -1.11 | R5 | G | NA | NA | NA | NA | NA | NA | NA | NA | RegulatoryFeature |
5 | 149445921 | rs216146 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | TFP.MAX | MCV-3 | NA | NA | NA | Gat1-primary,1.6676 | Gzf3-primary,1.6616 | Pbf1-primary,3.7868 | Skn7-primary,1.4239 | Skn7-primary,1.609 | NA | NA | NA | NA | NA | NA | 0.003 | 0.737 | 2.25 | R1 | T | NA | NA | NA | NA | NA | NA | NA | NA |
5 | 149446487 | rs216148 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | TFP.MAX | TFP.MYC | NA | NA | NA | LM152,2.1818 | LM152,2.2438 | LM197,2.7663 | Pax5,1.4035 | PPARG-RXRA,3.2188 | NA | NA | NA | NA | NA | NA | 0.001 | 0.368 | 1.16 | TF0 | A | NA | NA | NA | 0.290 | 0.440 | 0.250 | 0.470 | 0.090 |
5 | 149447628 | rs216150 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000513609,ENSG00000182578 | ENST00000515239,ENSG00000182578 | MCV-2 | NA | NA | NA | LM7,9.6604 | LM14,5.7656 | LM23,9.2765 | LM46,1.7805 | LM46,1.7393 | NA | NA | NA | NA | NA | NA | 0.000 | -0.398 | -1.47 | R3 | G | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
5 | 149450132 | rs10079250 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | TFP.CTCF | TFP.RAD21 | NA | NA | NA | Cgd2_3490,3.652 | Cgd2_3490,10.0422 | Cha4-primary,59.2578 | Leu3-primary,2.8451 | Pdr1-DBD-primary,3.4557 | NA | NA | NA | CSF1R,T,G,H,P,0.589,0.97,0.983215,0.264712 | CSF1R,T,C,H,R,0.442,0.95,0.983215,0.090019 | CSF1R,T,A,H,L,0.006,0.96,0.983215,0.316504 | NA | NM_005211,TypeII+,CAC->CGC,H->R,3.25 | NM_005211,TypeII+,CAC->CGC,H->R,2.75 | NM_005211,TypeII+,CAC->CGC,H->R,4.226 | NM_005211,TypeII+,CAC->CGC,H->R,3.316 | NM_005211,TypeII-,CAC->CGC,H->R,2.364 | NM_005211,TypeIII+,CAC->CGC,H->R,3.76 | NM_005211,TypeIII+,CAC->CGC,H->R,3.967 | NM_005211,TypeIII+,CAC->CGC,H->R,5.411 | NM_005211,TypeIII+,CAC->CGC,H->R,2.273 | NM_005211,TypeIII+,CAC->CGC,H->R,4.462 | NM_005211,TypeIII+,CAC->CGC,H->R,6 | NM_005211,TypeIII+,CAC->CGC,H->R,2.593 | NM_005211,TypeIII+,CAC->CGC,H->R,3.526 | NM_005211,TypeIII-,CAC->CGC,H->R,2.923 |
5 | 149454918 | rs12651699 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | NA | NA | NA | NA | LM35,5.1226 | LM52,2.3039 | LM77,5.0038 | LM85,3.3137 | LM145,10.0665 | NA | NA | NA | NA | NA | NA | 0.006 | 0.000 | 0 | R1 | C | NA | NA | NA | NA | NA | NA | NA | NA | Transcript | INTRONIC | 667 |
5 | 149459574 | rs13188584 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000504875,ENSG00000182578 | ENST00000394307,ENSG00000182578 | ENST00000502660,ENSG00000182578 | ENST00000511344,ENSG00000182578 | MCV-3 | NA | NA | NA | Asg1-DBD-primary,23.1567 | Gal4-primary,1.5472 | Hal9-primary,6.5637 | Hal9-primary,6.5637 | Mbp1-primary,1.5609 | NA | NA | NA | NA | NA | NA | 0.000 | -0.742 | -5.46 | R5 | C | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
5 | 149481535 | rs1465692 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000511344,ENSG00000182578 | NA | NA | chr5,149480001,149490000,chr5,149460001,149470000,27,Hi-C | chr5,149480001,149490000,chr5,177340001,177350000,38,Hi-C | chr5,149480001,149490000,chr7,102150001,102160000,194,Hi-C | chr5,149480001,149490000,chr5,154190001,154200000,5,Hi-C | NA | Fhl1-DBD-primary,2.456 | LM33,2.4677 | LM44,1.8498 | LM46,1.3889 | LM59,1.5167 | NA | NA | NA | NA | NA | NA | 0.004 | 1.214 | 1.97 | R2 | T | NA | NA | NA | NA | NA | NA | NA | NA | Intergenic |
5 | 149485772 | rs6865659 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000511344,ENSG00000182578 | MCV-3 | NA | chr5,149480001,149490000,chr5,149460001,149470000,27,Hi-C | chr5,149480001,149490000,chr5,177340001,177350000,38,Hi-C | chr5,149480001,149490000,chr7,102150001,102160000,194,Hi-C | chr5,149480001,149490000,chr5,154190001,154200000,5,Hi-C | NA | LM58,5.9133 | LM165,4.6582 | LM174,7.3932 | dl_1,2.3765 | Gfi,1.3755 | NA | NA | NA | NA | NA | NA | 0.004 | 0.713 | 2.4 | R5 | A | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
5 | 149489110 | rs1010101 | NM_005211,CSF1R | ENST00000286301,ENSG00000182578 | ENST00000511344,ENSG00000182578 | MCV-6 | NA | chr5,149480001,149490000,chr5,149460001,149470000,27,Hi-C | chr5,149480001,149490000,chr5,177340001,177350000,38,Hi-C | chr5,149480001,149490000,chr7,102150001,102160000,194,Hi-C | chr5,149480001,149490000,chr5,154190001,154200000,5,Hi-C | NA | LM12,1.8026 | LM31,1.6547 | LM44,1.3206 | LM54,1938.45 | LM117,2.1234 | NA | NA | NA | NA | NA | NA | 0.001 | 0.013 | 0.133 | R4 | C | NA | NA | NA | NA | NA | NA | NA | NA | Intergenic |
5 | 149492455 | rs11740298 | NM_005211,CSF1R | NM_002609,PDGFRB | ENST00000286301,ENSG00000182578 | ENST00000511344,ENSG00000182578 | ENST00000261799,ENSG00000113721 | ENST00000520851,ENSG00000113721 | TFP.TFAP2A | TFP.TFAP2C | TFP.SMARCC1 | TFP.STAT3 | NA | NA | NA | Aft1-primary,2.824 | Ceh-22,1.3236 | Cgd2_3490,1.341 | Cha4-primary,3.4829 | Rap1-FL-primary,1.6087 | NA | NA | NA | NA | NA | NA | 0.000 | -0.119 | -0.622 | TF1 | C | NA | NA | NA | NA | NA | NA |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Disease ID | 73 |
---|---|
Disease | fibromyalgia |
Case | (Waiting for update.) |